PCIA
VXRT

Prime Capital Investment Advisors’s Vaxart VXRT Stock Holding History

Prime Capital Investment Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-600
Closed -$3K – 507
2020
Q4 		$3K Buy
+600
New +$3.82K ﹤0.01% 434

Other funds holding VXRT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Prime Capital Investment Advisors's VXRT Position: Q1 2021 in Review

Prime Capital Investment Advisors sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 600 shares — an estimated $3K sold.

Prime Capital Investment Advisors first reported a position in VXRT in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

  • Prime Capital Investment Advisors reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 600 Vaxart shares in Q1 2021, an estimated $3K.
  • Prime Capital Investment Advisors first reported a position in Vaxart in Q4 2020 and held it in 1 quarter.
  • Prime Capital Investment Advisors's Vaxart position peaked at $3K in Q4 2020.
  • 159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2021, filed 7 May 2021.